Welcome to MutualFunds.com. Please help us personalize your experience.
Thank you for your submission, we hope you enjoy your experience

Select the one that best describes you
Mutualfunds logo

VGHAX Vanguard Health Care Adm

  • Fund
  • VGHAX
  • Price as of: Aug 08, 2016
  • $90.53
  • - $1.06
  • - 1.16%
  • Category
  • Health & Biotech Equities

VGHAX - Profile

Vitals

  • YTD Return -2.6%
  • 3 Yr Annualized Return 18.2%
  • 5 Yr Annualized Return 19.2%
  • Net Assets $50.7 B
  • Holdings in Top 10 43.2%

52 WEEK LOW AND HIGH

$90.53
$79.30
$98.30

Expenses

OPERATING RELATED FEES

  • Expense Ratio 0.31%

SALES FEES

  • Front Load N/A
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 18.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

STANDARD (TAXABLE)

$50,000

IRA

N/A

Investment Themes

CATEGORY

Health & Biotech Equities
  • Fund Type Open End Mutual Fund
  • Investment Style Health

Distributions

  • YTD Total Return -2.6%
  • 3 Yr Annualized Total Return 18.2%
  • 5 Yr Annualized Total Return 19.2%
  • Capital Gain Distribution Frequency None
  • Net Income Ratio 0.89%
DIVIDENDS
  • Dividend Yield N/A
  • Dividend Distribution Frequency None

Fund Details

  • Legal Name Vanguard Health Care Fund
  • Fund Family Name Vanguard
  • Inception Date Nov 12, 2001
  • Shares Outstanding N/A
  • Share Class Other
  • Currency USD
  • Domiciled Country United States
  • Manager Jean M. Hynes

Fund Description

The Vanguard Health Care Fund Admiral Shares (VGHAX) offers investors low-cost exposure to domestic and foreign companies involved in various aspects of the healthcare industry, such as pharmaceutical firms, medical supply companies, and research firms. Given its narrow focus, VGHAX is better suited for those looking to add complementary exposure to an already diversified portfolio.

The actively-managed fund seeks to maintain exposure across five primary subsectors: health services, medical products, specialty pharmaceuticals, major pharmaceuticals, and international markets. Fundamental research focuses on companies with high-quality balance sheets, strong management, and the potential for new products that will lead to above-average growth in revenue and earnings. VGHAX is managed by Wellington Management Company.

VGHAX - Performance

Return Ranking - Trailing

Period VGHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -2.6% -25.2% 18.9% 46.43% 3
1 Yr -2.4% -29.1% 15.0% 11.61% 1
3 Yr 18.2% * 4.7% 22.2% 5.50% 1
5 Yr 19.2% * 10.5% 23.7% 37.14% 2
10 Yr 11.9% * 8.3% 16.3% 45.54% 3

* Annualized


Return Ranking - Calendar

Period VGHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 4.1% -20.4% 13.8% 18.35% 1
2014 13.1% 13.1% 21.8% 100.00% 5
2013 30.6% 30.6% 65.2% 100.00% 5
2012 11.3% 9.6% 27.7% 80.00% 4
2011 5.2% -1.8% 18.0% 80.00% 4

Total Return Ranking - Trailing

Period VGHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
YTD -2.6% -25.2% 18.9% 46.43% 3
1 Yr -2.4% -32.7% 15.0% 8.93% 1
3 Yr 18.2% * 3.2% 22.2% 4.59% 1
5 Yr 19.2% * 9.9% 23.7% 31.43% 2
10 Yr 11.9% * 8.0% 16.3% 45.54% 3

* Annualized


Total Return Ranking - Calendar

Period VGHAX Return Category Return Low Category Return High Rank in Category (%) Quintile
2015 4.1% -20.4% 13.8% 18.35% 1
2014 18.9% 17.6% 22.2% 60.00% 3
2013 51.2% 51.1% 71.1% 80.00% 4
2012 19.9% 19.8% 39.6% 80.00% 4
2011 16.4% 13.8% 20.1% 40.00% 2

NAV & Total Return History

VGHAX - Holdings

Filings data as of: Mar 31, 2016

Concentration Analysis

VGHAX Category Low Category High VGHAX % Rank Quintile
Net Assets 50.7 B 23.8 M 50.7 B 0.89% 1
Number of Holdings 91 30 356 15.18% 3
Net Assets in Top 10 20.2 B 9.08 M 20.2 B 0.89% 1
Weighting of Top 10 43.2% 22.2% 68.4% 19.64% 3

Top 10 Holdings

  1. Allergan PLC 6.40%
  2. Merck & Co Inc 5.50%
  3. Bristol-Myers Squibb Company 6.51%
  4. UnitedHealth Group Inc 6.45%
  5. AstraZeneca PLC 3.68%
  6. Eli Lilly and Co 3.99%
  7. Medtronic PLC 2.93%
  8. Mylan NV 2.64%
  9. Boston Scientific Corp 2.54%
  10. Incyte Corp 2.51%

Asset Allocation

Weighting Category Low Category High VGHAX % Rank Quintile
Stocks
96.62% 87.51% 106.76% 24.11% 4
Cash
2.21% 0.00% 12.50% 10.71% 2
Other
1.18% -6.76% 2.31% 6.25% 2
Convertible Bonds
0.00% 0.00% 0.33% 3.57% 5
Preferred Stocks
0.00% 0.00% 1.48% 4.46% 5
Bonds
0.00% 0.00% 1.19% 3.57% 5

Stock Sector Breakdown

Weighting Category Low Category High VGHAX % Rank Quintile
Healthcare
91.49% 14.93% 99.47% 27.68% 5
Technology
3.46% 0.00% 64.47% 5.36% 2
Consumer Defense
1.45% 0.00% 2.38% 3.57% 1
Industrials
0.22% 0.00% 12.74% 12.50% 3
Financial Services
0.00% 0.00% 1.13% 6.25% 5
Real Estate
0.00% 0.00% 1.99% 1.79% 5
Energy
0.00% 0.00% 0.00% 0.89% 5
Communication Services
0.00% 0.00% 2.23% 1.79% 5
Utilities
0.00% 0.00% 1.25% 1.79% 5
Consumer Cyclical
0.00% 0.00% 4.23% 6.25% 5
Basic Materials
0.00% 0.00% 2.05% 3.57% 5

Stock Geographic Breakdown

Weighting Category Low Category High VGHAX % Rank Quintile
US
76.97% 62.67% 99.85% 27.68% 4
Non US
19.65% 0.14% 44.09% 6.25% 1

VGHAX - Expenses

Operational Fees

VGHAX Fees (% of AUM) Category Low Category High Rank in Category (%) Quintile
Expense Ratio 0.31% 0.10% 4.31% 68.75% 1
Management Fee 0.30% 0.08% 1.25% 19.64% 1
12b-1 Fee N/A 0.00% 1.00% N/A N/A
Administrative Fee N/A 0.01% 0.40% N/A N/A

Sales Fees

VGHAX Fees (% of AUM) Category Low Category High VGHAX Rank Quintile
Front Load N/A 3.50% 5.75% N/A N/A
Deferred Load N/A 1.00% 5.00% N/A N/A

Trading Fees

VGHAX Fees (% of AUM) Category Low Category High VGHAX Rank Quintile
Max Redemption Fee N/A 0.75% 2.00% N/A N/A

Turnover Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

VGHAX Fees (% of AUM) Category Low Category High VGHAX Rank Quintile
Turnover 18.00% 4.00% 249.00% 22.32% 1

VGHAX - Distributions

Dividend Yield Analysis

VGHAX Category Low Category High VGHAX % Rank Quintile
Dividend Yield N/A 0.01% 0.94% N/A N/A

Dividend Distribution Analysis

VGHAX Category Low Category High Category Mode
Dividend Distribution Frequency None Annually Quarterly Annually

Dividend Payout History


Net Income Ratio Analysis

VGHAX Category Low Category High VGHAX % Rank Quintile
Net Income Ratio 0.89% -2.26% 1.24% 2.68% 1

Capital Gain Distribution Analysis

VGHAX Category Low Category High Capital Mode
Capital Gain Distribution Frequency None Annually Semi-Annually Annually

VGHAX - Managers

Jean M. Hynes

Manager

Start Date

May 29, 2008

Tenure

8.18

Tenure Rank

11.5%

Jean M. Hynes, CFA, Senior Vice President, Managing Partner, and Global Industry Analyst, is involved in portfolio management and securities analysis at Wellington Management. Jean holds a BA in economics from Wellesley College (1991). She joined Wellington Management upon her graduation. She holds the Chartered Financial Analyst designation, and is a member of the CFA Institute and the Boston Security Analysts Society.


Tenure Analysis

Category Low

0.1

Category High

18.9

Category Average

8.99

Category Mode

1.6